Year: 2024

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...

United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)"...

Red Light Holland Commences Experimental Research on Psilocybin Truffles to Develop Process for Commercial Manufacturing of Natural-Source Active Pharmaceutical Ingredient

Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

- Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD...

TimeSmart.AI Announces Partnership with Leading EHR Provider PointClickCare to Revolutionize Contract Compliance and Clinician Invoicing in Skilled Nursing Facilities

TORONTO--(BUSINESS WIRE)--TimeSmart.AI, an emerging innovator in healthcare contract compliance and clinician payment efficiency, has developed an integration with PointClickCare Technologies...

error: Content is protected !!